SOLID TUMOR MALIGNANCIES
Clinical trials for SOLID TUMOR MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new SOLID TUMOR MALIGNANCIES trials appear
Sign up with your email to follow new studies for SOLID TUMOR MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Custom mRNA shots tested to fight advanced cancers
Disease control Not yet recruitingThis is an early safety study testing a personalized mRNA vaccine called RH125 for people with advanced solid tumors that have not responded to standard treatments. The study will enroll up to 36 participants to see if the vaccine, given alone or with an immunotherapy drug, is sa…
Matched conditions: SOLID TUMOR MALIGNANCIES
Phase: EARLY_PHASE1 • Sponsor: Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New cancer pill targets Hard-to-Treat tumors in early trial
Disease control Not yet recruitingThis early-stage study is testing an experimental oral medication called TYK-01054 in patients with advanced solid tumors that have stopped responding to standard treatments. The research aims to find the safest and most effective dose while checking if the drug can shrink tumors…
Matched conditions: SOLID TUMOR MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: TYK Medicines, Inc • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New targeted drug trial aims to slow advanced cancers by fixing genetic switches
Disease control Not yet recruitingThis study is testing an investigational pill called valemetostat for adults with advanced solid tumors that have stopped responding to standard treatments. It is specifically for people whose cancers have certain genetic changes affecting a cellular system called SWI/SNF. The go…
Matched conditions: SOLID TUMOR MALIGNANCIES
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Early test: can a common acid boost cancer treatment?
Disease control Not yet recruitingThis early-stage study aims to see if adding an oral malic acid supplement to standard immunotherapy is safe and might help control solid tumors like lung or colorectal cancer. It will involve about 30 adults already receiving immunotherapy. Researchers will check for side effect…
Matched conditions: SOLID TUMOR MALIGNANCIES
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Can a drug save hearing for cancer patients?
Symptom relief Not yet recruitingThis study is testing if a drug called Pedmark® can protect hearing in adults receiving cisplatin chemotherapy, a common cancer treatment that often causes hearing loss. The drug is already approved for children, but this trial will see if it's safe and effective for adults with …
Matched conditions: SOLID TUMOR MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: University of Arizona • Aim: Symptom relief
Last updated Apr 03, 2026 14:42 UTC
-
Scientists hunt for early warning signs of dangerous cancer drug reactions
Knowledge-focused Not yet recruitingThis study aims to find biological markers that can predict which cancer patients are likely to experience severe side effects from immunotherapy drugs. Researchers will collect various blood and health data from 160 adults with solid tumors before and after they start standard i…
Matched conditions: SOLID TUMOR MALIGNANCIES
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
Scientists hunt for blood test to predict cancer Patients' mental health risk
Knowledge-focused Not yet recruitingThis study aims to find biological markers in blood and tumor tissue that are linked to anxiety and depression in people with solid tumors. Researchers will enroll 100 cancer patients, assess their mental health, and analyze their samples. The goal is to create a tool to help doc…
Matched conditions: SOLID TUMOR MALIGNANCIES
Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC